1992
DOI: 10.1016/0378-1119(92)90261-m
|View full text |Cite
|
Sign up to set email alerts
|

GAL4 fusion vectors for expression in yeast or mammalian cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
193
0

Year Published

1993
1993
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 214 publications
(195 citation statements)
references
References 17 publications
2
193
0
Order By: Relevance
“…Plasmids-The following plasmids have previously been described: pCEP4F, which contains the cytomegalovirus immediate early promoter and an ATG sequence followed by the FLAG epitope (23); pBJ5-HD1-F, which encodes a carboxyl-terminal FLAG epitope-tagged HDAC1 (10); pME18S-FLAG-HDAC2, which expresses FLAG epitopetagged HDAC2 (14); pM2, pM3, and pSG424, which contain the Gal4 DNA-binding domain under the control of the SV40 promoter/enhancer (24,25); pGal4-mRPD3 (pGal4-HDAC2), which expresses a Gal4-* This work was supported by Grant MCB-9631067 from the National Science Foundation (to E. S.) and Grant MT-9186 from the Medical Research Council of Canada (to J. R. D.). The costs of publication of this article were defrayed in part by the payment of page charges.…”
Section: Methodsmentioning
confidence: 99%
“…Plasmids-The following plasmids have previously been described: pCEP4F, which contains the cytomegalovirus immediate early promoter and an ATG sequence followed by the FLAG epitope (23); pBJ5-HD1-F, which encodes a carboxyl-terminal FLAG epitope-tagged HDAC1 (10); pME18S-FLAG-HDAC2, which expresses FLAG epitopetagged HDAC2 (14); pM2, pM3, and pSG424, which contain the Gal4 DNA-binding domain under the control of the SV40 promoter/enhancer (24,25); pGal4-mRPD3 (pGal4-HDAC2), which expresses a Gal4-* This work was supported by Grant MCB-9631067 from the National Science Foundation (to E. S.) and Grant MT-9186 from the Medical Research Council of Canada (to J. R. D.). The costs of publication of this article were defrayed in part by the payment of page charges.…”
Section: Methodsmentioning
confidence: 99%
“…SUV39H1 SET (provided by T. Jenuwein) contains the SET domain downstream of an engineered nuclear localization sequence and localizes to the nucleus (30a). To construct GAL4 DNA binding domain (DBD) fusion proteins, SUV39H1 was cloned in frame with amino acids 1 to 147 of GAL4 in the pM3 vector (provided by R. Baer) (44). Reporter constructs for transient transcriptional assays contained a firefly luciferase gene with (pLUC/ GAL4) or without (pLUC) four GAL4 sites upstream of the myelomonocytic growth factor promoter (provided by R. Eisenman) (2).…”
Section: Methodsmentioning
confidence: 99%
“…As a positive control bait construct, we used the KOX1-KRAB domain (aa 1 ± 122) fused to the LexA DNA-binding domain. We detected strong interaction between this KOX1-KRAB bait and the TIF1b target in yeast, as seen from the growth of the yeast transformants in histidine-deÂźcient media and the detection of b-galactosidase activity in these transfor- The backbone plasmid for expression of fusion proteins was pM3-VP16-FLAG, derived from mammalian expression vector pM3 (Sadowski et al, 1992). The expressed fusion protein contains the N-terminus (amino acids 1 ± 147) of GAL4 (the DNA binding domain), and four copies of the VP16 activation domain.…”
mentioning
confidence: 90%